Chaired by:

Michael Callahan, M.D., DTM&H, Program Manager, Defense Science Office, DEFENSE ADVANCED RESEARCH PROJECTS AGENCY (DARPA)

Peter Hobart, Ph.D., Science Director, U.S. ARMY MEDICAL RESEARCH INSTITUTE FOR INFECTIOUS DISEASES

Michael Kurilla, M.D., Ph.D., Director, Office of BioDefense Research Affairs and Associate Director for BioDefense, NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES, NIH

Confirmed Speakers to Date:

Michael Goldblat, Ph.D., J.D., President & CEO, FUNCTIONAL GENETICS

Dennis Hruby, Ph.D., Chief Scientific Officer, SIGA TECHNOLOGIES INC.

Brian Livingston, Ph.D., Director of Preclinical Research, DYNAVAX TECHNOLOGIES CORPORATION

Heather Davis, Ph.D., Managing Director, COLEY PHARMACEUTICAL CANADA and Senior Vice President, Pharmaceutical R&D, COLEY PHARMACEUTICAL GROUP

Robert Hopkins, M.D., MPH & TM, Vice President, Clinical Development, EMERGENT BIOSOLUTIONS

Patrick Scannon, M.D., Ph.D., Founder, Executive Vice President, Chief Biotechnology Officer, and Member of the Board of Directors, XOMA LTD.

Mark Abdy, D.V.M., Ph.D., Veterinary Medical Officer, CENTER FOR BIOLOGICS EVALUATION AND RESEARCH (CBER), FDA (invited)

Download Symposium Agenda